{
    "Trade/Device Name(s)": [
        "Genomadix Cube CYP2C19 System"
    ],
    "Submitter Information": "Genomadix Inc.",
    "510(k) Number": "K220026",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123891"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NTI"
    ],
    "Summary Letter Date": "",
    "Summary Letter Received Date": "",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3360"
    ],
    "Regulation Name(s)": [
        "Drug Metabolizing Enzyme Genotyping System"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "toxicology"
    ],
    "Analyte(s)": [
        "CYP2C19 *2",
        "CYP2C19 *3",
        "CYP2C19 *17"
    ],
    "Specimen Type(s)": [
        "Genomic DNA from buccal swab"
    ],
    "Specimen Container(s)": [
        "Buccal swab"
    ],
    "Instrument(s)/Platform(s)": [
        "Genomadix Cube CYP2C19 Platform"
    ],
    "Method(s)/Technology(ies)": [
        "Polymerase Chain Reaction (PCR)",
        "Fluorescent probe detection",
        "Integrated DNA extraction and amplification"
    ],
    "Methodologies": [
        "Genotyping microarray",
        "PCR amplification",
        "Fluorescent oligonucleotide probe detection"
    ],
    "Submission Type(s)": [
        "System",
        "Platform",
        "Test Kit",
        "Cartridge",
        "Swab",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Genomadix Cube CYP2C19 System, an integrated sample-to-result PCR-based genotyping system for detecting CYP2C19 *2, *3, and *17 alleles from buccal swab DNA.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test to identify CYP2C19 *2, *3, and *17 genotypes from buccal swab DNA, aiding clinicians in determining therapeutic strategy for drugs metabolized by CYP2C19, used with the Genomadix Cube CYP2C19 Platform.",
    "fda_folder": "Toxicology"
}